Translating the molecular message of triple-negative breast cancer into targeted therapy
- PMID: 25351747
- DOI: 10.1158/1078-0432.CCR-14-2532
Translating the molecular message of triple-negative breast cancer into targeted therapy
Abstract
Triple-negative breast cancer (TNBC) has a poor prognosis with limited treatment options. Genomic analysis of TNBCs offers the opportunity to decode TNBC into biologically relevant subtypes with unique molecular targets. With further research, these findings may be translated into effective targeted therapeutic options.
©2014 American Association for Cancer Research.
Comment on
-
Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer.Clin Cancer Res. 2015 Apr 1;21(7):1688-98. doi: 10.1158/1078-0432.CCR-14-0432. Epub 2014 Sep 10. Clin Cancer Res. 2015. PMID: 25208879 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources